From: Relationship between vitamin D and coronary artery disease in Egyptian patients
 | Patients | Controls | p value |
---|---|---|---|
(n = 188) | (n = 131) | ||
Male (%) | 151 (80.3) | 84 (64.1) | 0.002 |
Age, years | 55 (50–62) | 52 (45–56) |  < 0.001 |
Diabetes mellitus (%) | 73 (38.8) | 30 (22.9) | 0.003 |
Hypertension (%) | 84 (44.7) | 63 (48.1) | 0.57 |
Smoking (%) | 74 (39.4) | 9 (6.9) |  < 0.001 |
Dyslipidaemia (%) | 164 (87.2) | 27 (20.6) |  < 0.001 |
Family history (%) | 0 (0) | 1 (0.8) | 0.41 |
Renal impairment (%) * | 13 (6.9) | 0 (0) | 0.001 |
Presenting symptoms (%) | |||
Chest pain | 163 (86.7) | Â | Â |
Dyspnoea | 25 (13.3) | Â | Â |
Clinical diagnosis (%) | |||
AMI | 108 (57.4) | Â | Â |
AP | 33 (17.6) | Â | Â |
OMI | 24 (12.8) | Â | Â |
UAP | 23 (12.2) | Â | Â |
Ejection fraction (%) | 47 (40–55) | 55 (55–60) |  < 0.001 |
Coronary angiography (%) | |||
Single-vessel disease | 60 (31.9) | Â | Â |
Two-vessel disease | 72 (38.3) | Â | Â |
Three-vessel disease | 56 (29.8) | Â | Â |
Culprit vessel (%) | |||
LAD | 107 (56.9) | Â | Â |
RCA | 43 (22.9) | Â | Â |
LCX | 32 (17) | Â | Â |
LMT | 6 (3.2) | Â | Â |
Intervention (%) | |||
PCI | 168 (89.4) | Â | Â |
CABG | 3 (1.6) | Â | Â |
Treatment (%) | |||
Aspirin | 188 (100) | Â | Â |
Ticagrelor | 107 (56.9) | Â | Â |
Clopidogrel | 73 (38.8) | Â | Â |
ACE-I | 159 (84.6) | Â | Â |
ARB | 5 (2.7) | Â | Â |
Statins | 188 (100) | Â | Â |
Nitrates | 106 (56.4) | Â | Â |
B-Blockers | 78 (41.5) | Â | Â |
CA | 2 (1.1) | Â | Â |